1. Home
  2. DIN vs AQST Comparison

DIN vs AQST Comparison

Compare DIN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$28.10

Market Cap

446.6M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.01

Market Cap

521.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIN
AQST
Founded
1958
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
446.6M
521.0M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
DIN
AQST
Price
$28.10
$4.01
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$29.67
$9.00
AVG Volume (30 Days)
380.5K
1.9M
Earning Date
05-06-2026
03-04-2026
Dividend Yield
2.69%
N/A
EPS Growth
N/A
N/A
EPS
1.11
N/A
Revenue
$879,300,000.00
$67,430,000.00
Revenue This Year
$3.61
$14.23
Revenue Next Year
$0.41
$58.36
P/E Ratio
$25.40
N/A
Revenue Growth
8.25
0.77
52 Week Low
$18.63
$2.20
52 Week High
$39.68
$7.55

Technical Indicators

Market Signals
Indicator
DIN
AQST
Relative Strength Index (RSI) 35.69 46.55
Support Level $27.52 $3.69
Resistance Level $28.64 $4.46
Average True Range (ATR) 1.18 0.21
MACD -0.17 -0.01
Stochastic Oscillator 13.71 23.44

Price Performance

Historical Comparison
DIN
AQST

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: